2014 NICE:心房颤动管理临床指南( CG180)

2014-06-19 NICE

2014年6月19日,《BMJ》杂志发表了NICE房颤管理指南2014版本,是对2006年指南的更新。

中文标题:

2014 NICE:心房颤动管理临床指南( CG180)

英文标题:

NICE guidelines [CG180] Atrial fibrillation: the management of atrial fibrillation

发布机构:

发布日期:

2014-06-19

简要介绍:

2014年6月19日,《BMJ》杂志发表了NICE房颤管理指南2014版本,是对2006年指南的更新。NICE基于现有的最佳证据对指南进行了更新,提出了推荐意见,特别是对一些不确定和争议问题。This guideline updates and replaces 'Atrial fibrillation' (NICE clinical guideline 36).Atrial fibrillation is the most common sustained cardiac arrhythmia, and estimates suggest its prevalence is increasing. If left untreated atrial fibrillation is a significant risk factor for stroke and other morbidities. Men are more commonly affected than women and the prevalence increases with age.The aim of treatment is to prevent complications, particularly stroke, and alleviate symptoms. Drug treatments include anticoagulants to reduce the risk of stroke and antiarrhythmics to restore or maintain the normal heart rhythm or to slow the heart rate in people who remain in atrial fibrillation. Non‑pharmacological management includes electrical cardioversion, which may be used to 'shock' the heart back to its normal rhythm, and catheter or surgical ablation to create lesions to stop the abnormal electrical impulses that cause atrial fibrillation.This updated guideline addresses several clinical areas in which new evidence has become available, including stroke and bleeding risk stratification, the role of new antithrombotic agents and ablation strategies.The recommendations apply to adults (18years or older) with atrial fibrillation, including paroxysmal (recurrent), persistent and permanent atrial fibrillation, and atrial flutter. They do not apply to people with congenital heart disease precipitating atrial fibrillation.


下载附件:

(需要扣积分10分)

版权声明:
本网站所有注明来源:“梅斯医学”或“MedSci”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,否则将追究法律责任。取得书面授权转载时,须注明“来源:梅斯医学”。其它来源的文章系转载文章,本网所有转载文章系出于传递更多信息之目的,转载内容不代表本站立场。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言